SCHEMBL23071019

SCHEMBL23071019

COc1ccc(C(=O)N2CC3(CNC3)C2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.58
CHRNB2 P17787 2/20 0.58
CHRNB4 P30926 2/20 0.58
CHRNA3 P32297 2/20 0.58
CHRNA7 P36544 2/20 0.58
CHRNA4 P43681 2/20 0.58
HPGD P15428 1/20 0.58
CYP3A4 P08684 5/20 0.55
CYP2C19 P33261 1/20 0.55
USP2 O75604 5/20 0.54
DRD2 P14416 1/20 0.53
DRD3 P35462 1/20 0.53
CYP2C9 P11712 3/20 0.52
HIF1A Q16665 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
MAPK1 P28482 1/20 0.52
POLB P06746 2/20 0.51
CYP1A2 P05177 3/20 0.51
KMT2A Q03164 1/20 0.51
NAMPT P43490 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17888382 0.83 GABRD (0.57) HPGDKMT2ANAMPTALDH1A1
SCHEMBL1914320 0.79 NAMPT (0.60) TSHRCHRNB2CHRNB4CHRNA3CHRNA7
SCHEMBL19226561 0.79 HPGD (0.60) TSHRHPGDSMN1; SMN2POLBKMT2A
SCHEMBL29530838 0.78 HSD11B1 (0.49) HPGDCYP2C19MAPK1POLBNAMPT
SCHEMBL23070974 0.77 TSHR (0.53) TSHRHPGDCYP3A4CYP2C19USP2
SCHEMBL20631562 0.77 HPGD (0.86) TSHRHPGDDRD2DRD3POLB
SCHEMBL208986 0.76 HPGD (0.73) TSHRCHRNB2CHRNB4CHRNA3CHRNA7
Piperazine SCHEMBL27980517 0.75 HPGD (0.71) TSHRCHRNB2CHRNB4CHRNA3CHRNA7
SCHEMBL2534411 0.74 HPGD (1.00) TSHRHPGDDRD2DRD3SMN1; SMN2
SCHEMBL30374883 0.73 GPR183 (0.77) GPR183

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112442050-B RET inhibitor, pharmaceutical composition and application thereof 广东东阳光药业股份有限公司 2024-08-09 CN disclosed
CN-112574235-B RET inhibitor, pharmaceutical composition and application thereof 广东东阳光药业股份有限公司 2024-01-16 CN disclosed
WO-2021057963-A1 RET INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME AND USE THEREOF 广东东阳光药业有限公司 2021-04-01 WO disclosed
WO-2021043209-A1 RET INHIBITOR, PHARMACEUTICAL COMPOSITION AND USE THEREOF 广东东阳光药业有限公司 2021-03-11 WO disclosed